Search results
Materials Processing Institute secures £4.2m investment towards decarbonising key industries
Business Live via Yahoo News UK· 2 days agoMr Walsh's appointment to the 75-year-old institute follows his most recent role as managing...
Celsius Rout Fails to Dent Street Fervor in Energy Drink Faceoff
Bloomberg· 6 days agoHave a confidential tip for our reporters? Celsius Holdings Inc. was hit with its worst quarter in...
Euro 2024: Why Austria is the tournament’s biggest surprise | CNN
CNN.com· 5 days agoIt is not uncommon to see certain teams emerge as dark horses or surprise packages at international...
Europe's top national dishes you MUST try
LoveFOOD via Yahoo News· 6 days agoFrom the hearty, winter-proof foods of Scandinavia to Mediterranean meals made with the finest sun-soaked produce, we've narrowed down Europe's best...
Deutsche Bank Hires Ex Goldman Sachs Banker Young Huh in Korea
Bloomberg via Yahoo Finance UK· 7 days ago(Bloomberg) -- Deutsche Bank AG has hired Jae Young Huh as head of investment banking coverage and...
Huge travel company goes bust leaving Brits facing cancellations
Daily Mail· 7 days agoIn a statement, Youtravel.com said: ‘The insolvency of FTI Touristik GmbH has had a significant...
Traders Complain of Losses Caused by German Power Market Glitch
Bloomberg· 6 days agoTraders are complaining about unfair losses made in the German power market because of an IT glitch...
CureVac Initiates Strategic Restructuring to Align Resources with Focus on High-Value mRNA Pipeline...
PharmiWeb· 2 days agoTÜBINGEN, GERMANY and BOSTON, MA / ACCESSWIRE / July 3, 2024 / CureVac N.V. (Nasdaq:CVAC) ("CureVac"), a global biopharmaceutical company developing a new class of transformative medicines based ...
GSK and CureVac to Restructure Collaboration into New Licensing Agreement (1)
PharmiWeb· 2 days agoLONDON, UK, TÜBINGEN, GERMANY and BOSTON, MA / ACCESSWIRE / July 3, 2024 / GSK plc (LSE/NYSE: GSK) and CureVac N.V. (Nasdaq:CVAC) today announced they have restructured their existing collaboration ...
Fecal Pancreatic Elastase Testing Market to Reach USD 31,842.3 Million by 2033 at a 7.6% of CAGR
PharmiWeb· 2 days agoThe fecal pancreatic elastase testing market is poised for significant growth, expected to increase from USD 15,306.7 million in 2023 to USD 31,842.3 million by 2033. This growth reflects a ...